 |
Previous Article | Next Article 
The Journal of Neuroscience, September 1, 2000, 20(17):6421-6430
Passive or Active Immunization with Myelin Basic Protein Promotes
Recovery from Spinal Cord Contusion
Ehud
Hauben1,
Oleg
Butovsky1,
Uri
Nevo1, 4,
Eti
Yoles1,
Gila
Moalem1, 2,
Eugenia
Agranov5,
Felix
Mor2,
Raya
Leibowitz-Amit1,
Evgenie
Pevsner6,
Solange
Akselrod4,
Michal
Neeman3,
Irun R.
Cohen2, and
Michal
Schwartz1
Departments of 1 Neurobiology,
2 Immunology, and 3 Biological Regulation, The
Weizmann Institute of Science, Rehovot 76100, Israel,
4 Department of Medical Physics, Tel-Aviv University,
Tel-Aviv 69978, Israel, 5 Beit Levinstein Hospital, Raanana
43100, Israel, and 6 Department of Neurosurgery, Sheba
Medical Center, Tel-Aviv University, Tel-Aviv 52621, Israel
Partial injury to the spinal cord can propagate itself, sometimes
leading to paralysis attributable to degeneration of initially undamaged neurons. We demonstrated recently that autoimmune T cells
directed against the CNS antigen myelin basic protein (MBP) reduce degeneration after optic nerve crush injury in rats. Here we
show that not only transfer of T cells but also active immunization with MBP promotes recovery from spinal cord injury. Anesthetized adult
Lewis rats subjected to spinal cord contusion at T7 or T9, using the
New York University impactor, were injected systemically with
anti-MBP T cells at the time of contusion or 1 week later. Another
group of rats was immunized, 1 week before contusion, with MBP
emulsified in incomplete Freund's adjuvant (IFA). Functional recovery
was assessed in a randomized, double-blinded manner, using the
open-field behavioral test of Basso, Beattie, and Bresnahan. The
functional outcome of contusion at T7 differed from that at T9
(2.9 ± 0.4, n = 25, compared with 8.3 ± 0.4, n = 12; p < 0.003). In
both cases, a single T cell treatment resulted in significantly better
recovery than that observed in control rats treated with T cells
directed against the nonself antigen ovalbumin. Delayed treatment
with T cells (1 week after contusion) resulted in significantly better recovery (7.0 ± 1; n = 6) than that
observed in control rats treated with PBS (2.0 ± 0.8;
n = 6; p < 0.01; nonparametric ANOVA). Rats immunized with MBP obtained a recovery score of
6.1 ± 0.8 (n = 6) compared with a score of
3.0 ± 0.8 (n = 5; p < 0.05) in control rats injected with PBS in IFA. Morphometric analysis, immunohistochemical staining, and diffusion anisotropy magnetic resonance imaging showed that the behavioral outcome was correlated with tissue preservation. The results suggest that T cell-mediated immune activity, achieved by either adoptive transfer or active immunization, enhances recovery from spinal cord injury by conferring effective neuroprotection. The autoimmune T cells, once reactivated at
the lesion site through recognition of their specific antigen, are a
potential source of various protective factors whose production is
locally regulated.
Key words:
CNS; beneficial autoimmunity; myelin basic protein; neurofilaments; spinal cord injury; secondary degeneration; neuroprotection; EAE
Copyright © 2000 Society for Neuroscience 0270-6474/00/20176421-10$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
S. K. Garg, R. Banerjee, and J. Kipnis
Neuroprotective Immunity: T Cell-Derived Glutamate Endows Astrocytes with a Neuroprotective Phenotype
J. Immunol.,
March 15, 2008;
180(6):
3866 - 3873.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. D. Reynolds, R. Banerjee, J. Liu, H. E. Gendelman, and R. L. Mosley
Neuroprotective activities of CD4+CD25+ regulatory T cells in an animal model of Parkinson's disease
J. Leukoc. Biol.,
November 1, 2007;
82(5):
1083 - 1094.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Rossignol, M. Schwab, M. Schwartz, and M. G. Fehlings
Spinal Cord Injury: Time to Move?
J. Neurosci.,
October 31, 2007;
27(44):
11782 - 11792.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Hohlfeld, M. Kerschensteiner, and E. Meinl
Dual role of inflammation in CNS disease
Neurology,
May 29, 2007;
68(22_suppl_3):
S58 - S63.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Ziv, A. Finkelstein, Y. Geffen, J. Kipnis, I. Smirnov, S. Shpilman, I. Vertkin, M. Kimron, A. Lange, T. Hecht, et al.
A Novel Immune-Based Therapy for Stroke Induces Neuroprotection and Supports Neurogenesis
Stroke,
February 1, 2007;
38(2):
774 - 782.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. Fleming, M. D. Norenberg, D. A. Ramsay, G. A. Dekaban, A. E. Marcillo, A. D. Saenz, M. Pasquale-Styles, W. D. Dietrich, and L. C. Weaver
The cellular inflammatory response in human spinal cords after injury
Brain,
December 1, 2006;
129(12):
3249 - 3269.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Ziv, H. Avidan, S. Pluchino, G. Martino, and M. Schwartz
Synergy between immune cells and adult neural stem/progenitor cells promotes functional recovery from spinal cord injury
PNAS,
August 29, 2006;
103(35):
13174 - 13179.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. W. Ip, A. Kroner, M. Bendszus, C. Leder, I. Kobsar, S. Fischer, H. Wiendl, K.-A. Nave, and R. Martini
Immune Cells Contribute to Myelin Degeneration and Axonopathic Changes in Mice Overexpressing Proteolipid Protein in Oligodendrocytes
J. Neurosci.,
August 2, 2006;
26(31):
8206 - 8216.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M H Barnett, A P. Henderson, and J W Prineas
The macrophage in MS: just a scavenger after all? Pathology and pathogenesis of the acute MS lesion
Multiple Sclerosis,
April 1, 2006;
12(2):
121 - 132.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C. G. Marcondes, G. C. Furtado, A. Wensky, M. A. Curotto de Lafaille, H. S. Fox, and J. J. Lafaille
Immune Regulatory Mechanisms Influence Early Pathology in Spinal Cord Injury and in Spontaneous Autoimmune Encephalomyelitis
Am. J. Pathol.,
June 1, 2005;
166(6):
1749 - 1760.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D. Boska, T. B. Lewis, C. J. Destache, E. J. Benner, J. A. Nelson, M. Uberti, R. L. Mosley, and H. E. Gendelman
Quantitative 1H Magnetic Resonance Spectroscopic Imaging Determines Therapeutic Immunization Efficacy in an Animal Model of Parkinson's Disease
J. Neurosci.,
February 16, 2005;
25(7):
1691 - 1700.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. D. Schwartz, C.-L. Chin, J. S. Shumsky, A. F. Jawad, B. K. Brown, S. Wehrli, A. Tessler, M. Murray, and D. B. Hackney
Apparent Diffusion Coefficients in Spinal Cord Transplants and Surrounding White Matter Correlate with Degree of Axonal Dieback After Injury in Rats
AJNR Am. J. Neuroradiol.,
January 1, 2005;
26(1):
7 - 18.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kerschensteiner, F. M. Bareyre, B. S. Buddeberg, D. Merkler, C. Stadelmann, W. Bruck, T. Misgeld, and M. E. Schwab
Remodeling of Axonal Connections Contributes to Recovery in an Animal Model of Multiple Sclerosis
J. Exp. Med.,
October 18, 2004;
200(8):
1027 - 1038.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Kipnis, H. Avidan, R. R. Caspi, and M. Schwartz
Dual effect of CD4+CD25+ regulatory T cells in neurodegeneration: A dialogue with microglia
PNAS,
October 5, 2004;
101(suppl_2):
14663 - 14669.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. J. Benner, R. L. Mosley, C. J. Destache, T. B. Lewis, V. Jackson-Lewis, S. Gorantla, C. Nemachek, S. R. Green, S. Przedborski, and H. E. Gendelman
Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson's disease
PNAS,
June 22, 2004;
101(25):
9435 - 9440.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. C. Byram, M. J. Carson, C. A. DeBoy, C. J. Serpe, V. M. Sanders, and K. J. Jones
CD4-Positive T Cell-Mediated Neuroprotection Requires Dual Compartment Antigen Presentation
J. Neurosci.,
May 5, 2004;
24(18):
4333 - 4339.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. B. Jones, D. P. Ankeny, Z. Guan, V. McGaughy, L. C. Fisher, D. M. Basso, and P. G. Popovich
Passive or Active Immunization with Myelin Basic Protein Impairs Neurological Function and Exacerbates Neuropathology after Spinal Cord Injury in Rats
J. Neurosci.,
April 14, 2004;
24(15):
3752 - 3761.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Hauben, A. Gothilf, A. Cohen, O. Butovsky, U. Nevo, I. Smirnov, E. Yoles, S. Akselrod, and M. Schwartz
Vaccination with Dendritic Cells Pulsed with Peptides of Myelin Basic Protein Promotes Functional Recovery from Spinal Cord Injury
J. Neurosci.,
September 24, 2003;
23(25):
8808 - 8819.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L Bo, C A Vedeler, H Nyland, B D Trapp, and S J Mork
Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration
Multiple Sclerosis,
August 1, 2003;
9(4):
323 - 331.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Bakalash, A. Kessler, T. Mizrahi, R. Nussenblatt, and M. Schwartz
Antigenic Specificity of Immunoprotective Therapeutic Vaccination for Glaucoma
Invest. Ophthalmol. Vis. Sci.,
August 1, 2003;
44(8):
3374 - 3381.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. N. Angelov, S. Waibel, O. Guntinas-Lichius, M. Lenzen, W. F. Neiss, T. L. Tomov, E. Yoles, J. Kipnis, H. Schori, A. Reuter, et al.
Therapeutic vaccine for acute and chronic motor neuron diseases: Implications for amyotrophic lateral sclerosis
PNAS,
April 15, 2003;
100(8):
4790 - 4795.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Kobsar, M. Berghoff, M. Samsam, C. Wessig, M. Maurer, K. V. Toyka, and R. Martini
Preserved myelin integrity and reduced axonopathy in connexin32-deficient mice lacking the recombination activating gene-1
Brain,
April 1, 2003;
126(4):
804 - 813.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Kipnis, T. Mizrahi, E. Hauben, I. Shaked, E. Shevach, and M. Schwartz
Neuroprotective autoimmunity: Naturally occurring CD4+CD25+ regulatory T cells suppress the ability to withstand injury to the central nervous system
PNAS,
November 26, 2002;
99(24):
15620 - 15625.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Mizrahi, E. Hauben, and M. Schwartz
The Tissue-Specific Self-Pathogen Is the Protective Self-Antigen: The Case of Uveitis
J. Immunol.,
November 15, 2002;
169(10):
5971 - 5977.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. W. Yong
Differential mechanisms of action of interferon-{beta} and glatiramer acetate in MS
Neurology,
September 24, 2002;
59(6):
802 - 808.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Schori, F. Lantner, I. Shachar, and M. Schwartz
Severe Immunodeficiency Has Opposite Effects on Neuronal Survival in Glutamate-Susceptible and -Resistant Mice: Adverse Effect of B Cells
J. Immunol.,
September 15, 2002;
169(6):
2861 - 2865.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. B. Jones, D. M. Basso, A. Sodhi, J. Z. Pan, R. P. Hart, R. C. MacCallum, S. Lee, C. C. Whitacre, and P. G. Popovich
Pathological CNS Autoimmune Disease Triggered by Traumatic Spinal Cord Injury: Implications for Autoimmune Vaccine Therapy
J. Neurosci.,
April 1, 2002;
22(7):
2690 - 2700.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Hauben, A. Ibarra, T. Mizrahi, R. Barouch, E. Agranov, and M. Schwartz
Vaccination with a Nogo-A-derived peptide after incomplete spinal-cord injury promotes recovery via a T-cell-mediated neuroprotective response: Comparison with other myelin antigens
PNAS,
December 18, 2001;
98(26):
15173 - 15178.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Kipnis, E. Yoles, H. Schori, E. Hauben, I. Shaked, and M. Schwartz
Neuronal Survival after CNS Insult Is Determined by a Genetically Encoded Autoimmune Response
J. Neurosci.,
July 1, 2001;
21(13):
4564 - 4571.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Yoles, E. Hauben, O. Palgi, E. Agranov, A. Gothilf, A. Cohen, V. Kuchroo, I. R. Cohen, H. Weiner, and M. Schwartz
Protective Autoimmunity Is a Physiological Response to CNS Trauma
J. Neurosci.,
June 1, 2001;
21(11):
3740 - 3748.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. N. Whitaker
The Potential for Harm or Benefit From Inflammatory Processes in Stroke
Arch Neurol,
April 1, 2001;
58(4):
674 - 674.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Schori, J. Kipnis, E. Yoles, E. WoldeMussie, G. Ruiz, L. A. Wheeler, and M. Schwartz
Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hypertension: Implications for glaucoma
PNAS,
March 1, 2001;
(2001)
41609498.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. Fisher, H. Levkovitch-Verbin, H. Schori, E. Yoles, O. Butovsky, J. F. Kaye, A. Ben-Nun, and M. Schwartz
Vaccination for Neuroprotection in the Mouse Optic Nerve: Implications for Optic Neuropathies
J. Neurosci.,
January 1, 2001;
21(1):
136 - 142.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Schori, J. Kipnis, E. Yoles, E. WoldeMussie, G. Ruiz, L. A. Wheeler, and M. Schwartz
Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hypertension: Implications for glaucoma
PNAS,
March 13, 2001;
98(6):
3398 - 3403.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|